|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | |||||||||||||||||||
| Cash | |||||||||||||||||||
| Accounts receivable, net | |||||||||||||||||||
| Costs capitalized to obtain revenue contracts | |||||||||||||||||||
| Prepaid expenses | |||||||||||||||||||
| Other receivable | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Office Equipment | |||||||||||||||||||
| Less Depreciation | |||||||||||||||||||
| Equipment, net | |||||||||||||||||||
| Patents | |||||||||||||||||||
| Less Amortization | |||||||||||||||||||
| Capitalized internal-use software | |||||||||||||||||||
| Intellectual property, net | |||||||||||||||||||
| Right-of-use asset | |||||||||||||||||||
| Security deposit | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued expenses | |||||||||||||||||||
| Operating lease liability | |||||||||||||||||||
| Related party loans | |||||||||||||||||||
| Stock issuable | |||||||||||||||||||
| Deferred revenue | |||||||||||||||||||
| Related-party loans | |||||||||||||||||||
| Related-party notes payable | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Operating lease liability, net of current portion | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Preferred stock, $0.0001 par value; 5,000,000 shares authorized and none issued and outstanding | |||||||||||||||||||
| Common stock, $0.0001 par value; 50,000,000 shares authorized and 3,892,979 shares issued and outstanding at June 30, 2026 and December 31, 2025 | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Subscription receivable | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total stockholders’ deficit | |||||||||||||||||||
| Total liabilities and stockholders’ deficit | |||||||||||||||||||
Loading...
